Objective To identify factors that affect the prognosis of patients with acute myocardial infarction (AMI) combined with cardiogenic shock (CS), in order to provide reference for predicting prognosis and propose possible measures to improve prognosis in such patients.
Methods A retrospective analysis was performed on the clinical data of patients with AMI and CS who visited the Department of Emergency Medicine of the Second Hospital of Hebei Medical University from December 2018 to December 2021, including gender, age, body mass index (BMI); past history of smoking, coronary heart disease, arrhythmia, diabetes, hypertension, hyperlipidemia, and cerebrovascular disease; APACHE Ⅱ score, highest vasoactive-inotropic score (VIS) within 24 hours of admission, and fastest heart rate within 24 hours of admission; the worst auxiliary examination values within 24 hours after admission: blood lactate, white blood cell count (WBC), cardiac troponin I (cTnI) , alanine aminotransferase (ALT), total bilirubin (TBil), creatinine (Cr), serum potassium, left ventricular end diastolic diameter (LVEDD), left ventricular ejection fraction(LVEF); whether to use continuous renal replacement therapy (CRRT), intra-aortic balloon counterpulsation (IABP), or extracorporeal membrane oxygenation (ECMO), etc. The patients were divided into either a survival group or a death group based on the prognosis after 30 days of onset. Univariate analysis was used to compare the differences in the above indicators between the two groups. Logistic regression analysis was used to identify independent risk factors affecting the prognosis of patients with AMI combined with CS, and receiver operating characteristic (ROC) curves were drawn to evaluate the predictive value of the identified risk factors on patient prognosis. According to whether ECMO or IABP was used, the patients were divided into a non-ECMO group and an ECMO group, or a non-IABP group and an IABP group, and the differences in APACHE Ⅱ score and VIS were compared between groups.
Results Among 97 patients, 62 (63.9%) survived for 30 days and 35 (36.1%) died. Compared with the survival group, the APACHE Ⅱ score, VIS, WBC, and blood lactate in the death group were significantly increased, and the proportion of patients using IABP in the death group was significantly increased. Logistic regression analysis showed that WBC and blood lactate were independent risk factors affecting the 30-day prognosis of AMI patients with CS [odds ratio (OR)=1.137, 95% confidence interval (CI): 1.012-1.278, P<0.05; OR=1.166, 95%CI: 1.025-1.326, P<0.05]. ROC curve analysis showed that, using a cutoff value of 15.35×109/L, the AUC of WBC in predicting prognosis was 0.710, with a sensitivity of 60.0% and specificity of 77.4%. When the cutoff value was 6.05 mmol/L, the AUC of blood lactate is 0.756, with a sensitivity of 85.7% and specificity of 67.7%. Compared with the non-ECMO group, the APACHE Ⅱ score and VIS in the ECMO group were significantly increased. Compared with the non-IABP group, the VIS of the IABP group was significantly higher (P<0.05).
Conclusion WBC and blood lactate are independent risk factors affecting the prognosis of patients with AMI combined with CS. The highest WBC >15.35×109/L and the highest lactate value >6.05 mmol/L within 24 hours of admission indicate a poor prognosis. Due to the fact that AMI patients with CS supported by IABP and ECMO are more critical, these support measures cannot improve their prognosis.